Figure 1: Alvesco® reduces the percentage of eosinophils in late-phase (small-airways-sampled) sputum2
Alvesco® also significantly increases Asthma Control Test™ (ACT) scores2 (Figure 2) and reduces small airway hyperresponsiveness.3 Read more
Figure 2: Alvesco® increases Asthma Control Test (ACT) scores2
See the section on Targeting small airways for more information on how Alvesco® targets this lung region.
References:
Thanks to high protein-binding and low oral bioavailability, Alvesco® minimizes systemic side effects.
Alvesco® has a unique pharmacological profile which enables it to target inflammation, whilst minimizing side effects.
Find out more about how to use the Alvesco® inhaler correctly.
Tell your colleagues about the benefits of Alvesco® by sharing this page to them.